Piezo1’s pleiotropic roles in cancer reflect tissue-specific mechanotransduction programs: pro-fibrotic/pro-tumorigenic in liver diseases, yet tumor-suppressive in NSCLC and gastric cancer. This evidence concerns the gene PIEZO1 and non-small cell lung carcinoma.